India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
Advances deployment of mRNA technology across vaccines and therapeutics development
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
CDSCO to fast-track trials and approval for COVID19 vaccine
Releasing it, Union Minister Jitendra Singh said India needs its database for Indian research and solutions.
Deal for 100 million doses with additional 100 million through 2023
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Startup receives US $ 5 million in first round of funding
_logo_256_384.jpg){kind=logo}
It supports sequencing-based COVID 19 surveillance in India
Five seats reserved for Wards of COVID warriors in central MBBS admission
Subscribe To Our Newsletter & Stay Updated
